California Public Employees Retirement System’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
RG
BG
JJ
AG
CC
California Public Employees Retirement System's FATE Position: Q1 2023 in Review
California Public Employees Retirement System sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 158,802 shares — an estimated $1.6M sold.
California Public Employees Retirement System first reported a position in FATE in Q2 2018 and held it in 19 quarters. The position peaked at $15.7M in Q4 2020. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.
- California Public Employees Retirement System reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
- California Public Employees Retirement System sold 158,802 Fate Therapeutics shares in Q1 2023, an estimated $1.6M.
- California Public Employees Retirement System first reported a position in Fate Therapeutics in Q2 2018 and held it in 19 quarters.
- California Public Employees Retirement System's Fate Therapeutics position peaked at $15.7M in Q4 2020.
- 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.
Based on California Public Employees Retirement System's 13F filing for Q1 2023, filed 12 May 2023.